NJ State Employees Deferred Compensation Plan »

Revance Therapeutics shares owned by NJ State Employees Deferred Compensation Plan

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by NJ State Employees Deferred Compensation Plan from 13F filings

Historical chart of NJ State Employees Deferred Compensation Plan investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by NJ State Employees Deferred Compensation Plan consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by NJ State Employees Deferred Compensation Plan

Quarter filed Position value Share count Share price at filing
2023-12-31 $157k 18k 8.79
2023-09-30 $205k 18k 11.47
2023-06-30 $453k 18k 25.31
2023-03-31 $577k 18k 32.21
2022-12-31 $330k 18k 18.46
2022-09-30 $483k 18k 26.98